KCNQ1 and type 2 diabetes mellitus: These studies clearly demonstrated the utility of extending T2D GWAS to non-European populations; association of the KCNQ1 variants with T2D was not detected in previous European GWAS, due to markedly lower frequency of the risk allele in Europeans (5% versus 40%), resulting in dramatically reduced power.